Keywords: s6 کیناز ریبوزومی; BB; bevacizumab-bevacizumab; BP; bevacizumab followed by panitumumab; CA9; carbonic anhydrase 9; CRC; colorectal cancer; DEGs; differentially expressed genes; EGFR; epidermal growth factor receptor; EPHA2; ephrin type-A receptor 2; FASN; fatty acid syntha
مقالات ISI s6 کیناز ریبوزومی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: s6 کیناز ریبوزومی; Pin1; the peptidyl-prolyl cis-trans isomerase; SRC-3/AIB1; steroid receptor coactivator 3; FAK; focal adhesion kinase; Mcl-1; myeloid cell leukemia-1; p70S6K; ribosomal S6 kinase; Stat3; signal transducers and activators of transcription 3; PKB/Akt; serin
Keywords: s6 کیناز ریبوزومی; AC; adenylyl cyclase; AKT; protein kinase B; AMPK; AMP-activated protein kinase; AnR; androgen receptor; ARF6; ADP ribosylation factor 6; CaMK; Ca2+-calmodulin dependent kinase; CaMKK; CaMK kinase; cAMP; cyclic adenosine 3â²,5â²-monophosphate; CDK5; cyc
Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells
Keywords: s6 کیناز ریبوزومی; α-MSH; α-melanocyte stimulating hormone; BISA; bisabolangelone; cAMP; cyclic adenosine monophosphate; CREB; cAMP-responsive element-binding protein; DOPA; 3, 4-dihydroxyphenylalanine; ESS; ethanolic extract of Sargassum serratifolium; ERK; extracellular
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy
Keywords: s6 کیناز ریبوزومی; Epilepsy; Rapamycin; Everolimus; Pharmacokinetics; Tolerability; Levetiracetam; AKT; protein kinase B; ASD; anti-seizure drug; 4E-BP1; initiation factor 4E binding protein; HPβCD; hydroxypropyl-Ã-cyclodextrin; MTD; maximal tolerated dose; MES-T; maximal
Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1
Keywords: s6 کیناز ریبوزومی; A2AR; adenosine A2A receptor; AP-1; activator protein 1; BLC; B-lymphocyte chemoattractant; BMDM; bone marrow derived macrophage; CREB; cAMP response element-binding protein; DUSP1; dual specific phosphatase; Epac; exchange protein activated by cAMP; ERK;
Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components
Keywords: s6 کیناز ریبوزومی; mTOR; Mamalian target of rapamycin; PI3K; phosphoinositide 3-kinase related kinase; mTORC1; mTOR complex 1; mTORC2; mTOR complex 2; AMP; Adenosine monophosphate; ATP; Adenosine triphosphate; S6K; ribosomal S6 Kinase; 4E-BP1; eukaryotic initiation factor 4
Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration
Keywords: s6 کیناز ریبوزومی; FGFR2; FGF2; Ribosomal S6 kinase; RSK2; Breast cancer; Migration;
Phosphoprotein enriched in astrocytes (PEA)-15: A potential therapeutic target in multiple disease states
Keywords: s6 کیناز ریبوزومی; PEA-15; ERK1/2; Proliferation; Apoptosis; Cancer; Type 2 diabetes; CaMKII; calcium/calmodulin-dependent protein kinase II; DED; death effector domain; DISC; death initiation signalling complex; ERK1/2; extracellular signal-regulated kinases 1/2; FADD; Fas
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells
Keywords: s6 کیناز ریبوزومی; CSE1L; chromosome segregation 1-like; AKT1/AKT2; v-akt murine thymoma viral oncogene homolog 1 and 2; Ran; Ras-related nuclear protein; RanBP3; Ran-binding protein-3; RSK; ribosomal S6 kinase; Ovarian cancer; Chromosome segregation 1-like protein CSE1L; E
Synthetic Lethality Screen Identifies RPS6KA2 as Modifier of Epidermal Growth Factor Receptor Activity in Pancreatic Cancer
Keywords: s6 کیناز ریبوزومی; EGFR; epidermal growth factor receptor; RNAi; RNA interference; RSK; ribosomal S6 kinase; PARP; poly(ADP-ribose) polymerase;
TPCK inhibits AGC kinases by direct activation loop adduction at phenylalanine-directed cysteine residues
Keywords: s6 کیناز ریبوزومی; TPCK; N-alpha-tosyl-l-phenylalanyl chloromethyl ketone; PDK1; 3-phosphoinositide dependent protein kinase-1; AGC; related to protein kinase A, protein kinase G and protein kinase C; RSK; ribosomal S6 kinase; S6K; S6 kinase; PKA; protein kinase A; ERK; ext
C/EBPβ enhances NF-κB-associated signalling by reducing the level of IκB-α
Keywords: s6 کیناز ریبوزومی; NF-κB; nuclear factor-κB; C/EBP; CCAAT/enhancer-binding protein; IκB; inhibitor of NF-κB; TNF; tumor necrosis factor; LPS; bacterial lipopolysaccharide; IKK; IκB kinase; C/EBPβwt; C/EBPβ wild type cells; C/EBPβko; C/EBPβ knock out cells; FCS;
P90 Ribosomal s6 kinase 2 negatively regulates axon growth in motoneurons
Keywords: s6 کیناز ریبوزومی; Rsk2; Motoneuron; Erk; Coffin–Lowry syndrome; Axon; Ribosomal s6 kinase
Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1
Keywords: s6 کیناز ریبوزومی; Signal transduction; Ribosomal S6 kinase; Ubiquitination; Regulation; ROC1 ubiquitin ligase; Stability
A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats
Keywords: s6 کیناز ریبوزومی; Akt/PKB; protein kinase B; Apaf-1; apoptotic protease activating factor-1; JNK; c-Jun N-terminal kinase; LEHD; Leu-Glu-His-Asp acid; MAPK; mitogen-activated protein kinase; MPP+; 1-methyl-4-phenylpyridinium ion; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydrop
Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway
Keywords: s6 کیناز ریبوزومی; PI3K catalytic subunit; AKT1; Ribosomal S6 kinase; Cell motility; Cell growth; siRNA